Abstract
Johnson & Johnson is a holding company that comprises more than 250 healthcare
companies located in 57 countries throughout the world. The group' s primary
focus is on products related to human health and well-being. It is the world' s
leading consumer health company, the world' s largest and most diverse medical
devices and diagnostics company, the world' s fourth-largest biologics company
and the world' s seventh-largest pharmaceuticals company.
Johnson & Johnson' s structure is based around three business segments -
Medical Devices & Diagnostics, Pharmaceutical and Consumer.
- The Medical Devices & Diagnostics segment is divided into seven franchises
that are organised into the Surgical Care and Comprehensive Care Groups.
Surgical Care consists of DePuy' s orthopaedic joint reconstruction, spinal
care and sports medicine products, Ethicon' s surgical care and women' s health
products, and Ethicon Endo-Surgery' s minimally-invasive surgical products.
Comprehensive Care includes Cordis' circulatory disease management products,
Diabetes Care' s blood glucose monitoring and insulin delivery products,
Ortho-Clinical Diagnostics' professional diagnostic products, and Vision
Care' s disposable contact lenses.
- The Pharmaceutical segment includes products in the following therapeutic
areas: anti-infective, antipsychotic, cardiovascular, contraceptive,
dermatology, gastro-intestinal, haematology, immunology, neurology, oncology,
pain management, urology and virology.
- The Consumer segment includes a broad range of products used in the baby
care, skin care, oral care, wound care and women' s healthcare fields, as well
as nutritional and over-the-counter pharmaceutical products.
Among the key company acquisitions that took place within the Medical Devices
& Diagnostics segment during 2008 and the first quarter of 2009 were: SurgRx,
developer of the advanced bipolar tissue sealing system used in the Enseal
range of devices; Omrix Biopharmaceuticals, a developer of biosurgical and
immunotherapy products; Mentor, a supplier of products for the aesthetic
market; and Amic, a developer of in vitro diagnostic (IVD) technologies.
SurgRx is reported as part of Ethicon Endo-Surgery' s business, Mentor and
Omrix form part of the Ethicon franchise, while Amic is part of Ortho-Clinical
Diagnostics.
Recent significant divestitures within the Medical Devices & Diagnostics
business segment included Ethicon' s sale of its Professional Wound Care
division in the fourth quarter of 2008. In addition, in December 2008, Johnson
& Johnson' s Independence Technology announced that it would cease sales and
marketing of its principal product, the iBOT Mobility System, in January 2009.
The company said demand for the iBOT system had not proven sufficient to
create a sustainable market. The company will continue to provide technical
support and service to iBOT Mobility System owners until the end of 2013, at
which time the company is expected to close.
In 2008, Johnson & Johnson reported net earnings of US$12.9 billion on sales
of US$63.7 billion. The group has approximately 118,700 employees worldwide.
This report focuses on the activities and performance of Johnson & Johnson' s
Medical Devices & Diagnostics business. Separate profiles are published on the
following Johnson & Johnson subsidiaries - Cordis, DePuy, Ethicon, Mentor,
Ethicon Endo-Surgery, LifeScan (including Animas), Therakos and Vistakon.
This company report provides
- Overview
- Key contact information
- Introduction to the company and its current activities
- Summary of its financial performance
- Who are the company' s major competitors?
- Key recent events in an "at a glance" format
- Financial Review
- Current year and annual financial data, including revenue breakdowns by
product area and geographic region (if available)
- Table providing in-depth five-year financial analysis
- Employee data, including breakdown by company division and geographic
location
- Strategic Focus
- Investigates the company' s aims and its areas of focus
- Products
- Core product areas, key brands, product approvals and launches
- Research and Development
- How much has been invested in R&D?
- Where is the research based?
- What alliances and agreements does the company have and with whom?
- Manufacturing and Distribution
- Identifying the company' s manufacturing locations
- Sales and marketing facilities
- Agreements
- With whom has the company reached agreements and what do they involve?
- Key contracts awarded
- Mergers, Acquisitions, Minority Investments and Divestments
- Litigation
- Key Corporate Events
|
Related Report
|
View Cart
